Randomized controlled study was conducted to evaluate the efficacy of Sanyrene® vs. control intervention for acute radiation dermatitis in patients receiving radiotherapy. This trial suggests that Sanyrene is effective on preventing serious radiation dermatitis and improving skin related quality of life in patients with breast cancer or head and neck cancer receiving radiotherapy.
